Monthly archive | PharmaTutor

22 June 2026

India Prohibits 16 Fixed Dose Drug Combinations Following Expert Safety Review

Ministry of Health and Family Welfare has prohibited the manufacture, sale and distribution of 16 Fixed Dose Combinations (FDCs) for human use across India with immediate effect.

The decision was taken under Section 26A of the Drugs and Cosmetics Act, 1940, following an extensive scientific review of drug combinations available in the Indian market. The move forms part of the government's ongoing efforts to ensure that only scientifically validated, safe and therapeutically justified medicines remain available to patients.

22 June 2026

Jan Aushadhi Network Crosses 19,200 Stores as India Strengthens Pharma Manufacturing and Healthcare Access

India's pharmaceutical sector has undergone a significant transformation over the past decade, driven by a combination of affordable healthcare initiatives, domestic manufacturing incentives, and innovation-focused policies. According to the Ministry of Chemicals and Fertilizers, the country has expanded access to low-cost medicines while simultaneously strengthening its position as a global pharmaceutical manufacturing hub.

22 June 2026

Alembic Gains Strategic Edge in US Oncology Market with Tentative Approval for Binimetinib 45 mg Tablets

Alembic Pharmaceuticals Limited has announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Binimetinib Tablets, 45 mg. The company had earlier secured tentative approval for the 15 mg strength of the same drug.

The approved generic product is therapeutically equivalent to Mektovi Tablets, 15 mg, marketed by Array BioPharma. Binimetinib is a kinase inhibitor used in combination with encorafenib for the treatment of patients with specific forms of advanced cancer.

PCI Pharmacist Recruitment, Promotion and Service Regulations 2025 Explained

21 June 2026

47 posts for Pharmaceutical and Life Sciences, Chemistry, Biochemistry, Biotechnology candidates at NBRI

Conservation and utilization of Botanical wealth of India for National Botanical Research Institute and Pharmaceutical and Life Sciences, Chemistry, Biochemistry, Biotechnology candidates require at NBRI

21 June 2026

Pharma, Biotechnology Fellowship for Vascular Dementia and Metabolic Dysfunction at NIPER

Candidates with M.S./M.Pharm in Pharmacology/Pharmacology and Toxicology, M.Sc. in Medical Pharmacology/M.Sc. Biotechnology, PG in AYUSH courses or similar disciplines with qualification of NET/GATE/GPAT/relevant national level competitive exam and research experience

21 June 2026

U.S.-India TRUST Fellowship

The initiative is a collaboration among the U.S. Consulate General Chennai, Manipal Academy of Higher Education (MAHE), Indian Institute of Science (IISc), Indian Institute of Technology Madras (IITM), and founding sponsors Pratiksha Trust and Mazumdar Shaw Philanthropy (MSP).

21 June 2026

Career Opportunities at National Centre for Disease Control for Pharma Graduates

B.Pharma or Bsc. Statistics/ Biostatistics/ Economics/Mathematics/ Data Science/ Computer Science or Life Science. Broad knowledge and understanding of disease surveillance system, epidemiology including diseases of Public Health importance. National Institute of Communicable Diseases

21 June 2026

Pharma or Chemistry Job under CSIR-FIRST Funded Project at Indian Institute of Integrative Medicine

M.Sc./ M.Pharm/ M.S. in Chemistry / Analytical Chemistry / Pharmaceutical Chemistry / Pharmacognosy / Natural Products Chemistry from a recognized university or equivalent.